Northern Trust Corp Leap Therapeutics, Inc. Transaction History

Northern Trust Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.29 - $0.72 $7,647 - $18,986	26,370 Added 20.84%	152,931 $51,000
Q3 2022 Nov 14, 2022	BUY	$0.92 - $9.3 $14,203 - $143,582	15,439 Added 13.89%	126,561 $111,000
Q4 2021 Feb 08, 2022	BUY	$2.08 - $3.65 $77,315 - $135,674	37,171 Added 50.26%	111,122 $360,000
Q3 2021 Nov 15, 2021	SELL	$1.35 - $4.01 $15,002 - $44,563	-11,113 Reduced 13.06%	73,951 $297,000
Q1 2021 May 12, 2021	BUY	$1.82 - $3.01 $6,912 - $11,431	3,798 Added 4.67%	85,064 $162,000
Q4 2020 Feb 11, 2021	BUY	$1.49 - $2.37 $26,653 - $42,394	17,888 Added 28.22%	81,266 $183,000
Q3 2020 Nov 16, 2020	BUY	$1.68 - $2.17 $28,600 - $36,942	17,024 Added 36.73%	63,378 $125,000
Q2 2020 Aug 14, 2020	BUY	$1.39 - $2.84 $32,791 - $66,998	23,591 Added 103.64%	46,354 $97,000
Q3 2019 Nov 13, 2019	BUY	$1.17 - $2.36 $26,632 - $53,720	22,763 New	22,763 $27,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $344M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.